| Channel | Publish Date | Thumbnail & View Count | Download Video |
|---|---|---|---|
 | Publish Date not found |  0 Views |
More information: https://www.4ipcouncil.com/research/crispr-processes-patents-green-biotechnology-intellectual-property-licensing-platforms-and-clearing-houses-summary
A strong patent system is necessary to enable innovation by encouraging investment in R&D and promoting the dissemination of knowledge, including through licensing, as this is considered crucial for the development and commercialization of new products. The new genomic techniques (NGTs) defined by the EU in 2021 include Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) that can selectively modify DNA sequences in a genome. More than 11,000 CRISPR-related patent applications have already been filed worldwide, the majority of which are in the US and China. The proliferation of patents on CRISPR for green biotechnology applications and the dispute between two of the technology's inventors (UC Berkeley and the Broad Institute of MIT, US) may hinder innovation. With regard to IP and patent protection, this webinar explores:
– The conditions and possibilities of alternative licensing models to overcome the difficulties arising from the complex patent landscape of CRISPR technology.
– Patent pools and clearing houses are the two models attracting the most interest.
– Some major platforms with their characteristics will be presented.
This webinar is based on a forthcoming research paper entitled “CRISPR Processes Patents in Green Biotechnology: the Benefits of Patent Pools and Clearing Houses,” written by Dr. Agnes Ricroch.
Please take the opportunity to connect and share this video with your friends and family if you find it helpful.
